(Total Views: 390)
Posted On: 06/06/2019 2:30:52 AM
Post# of 36542
What is important. Joe’s health and return to gmin’s find- a treatment for triple negative breast cancer by $gnbt and $mrk
NSABP FB-14
A Phase II Clinical Trial of Pembrolizumab in Combination with the AE37 Peptide Vaccine in Patients with Metastatic-Triple-Negative Breast Cancer
Protocol Chair: Leisha A. Emens, MD, PhD
Protocol Officer: Samuel Jacobs, MD
Primary Objective: To establish the recommended biologic dose of AE37 in combination with pembrolizumab that will enhance the tumor-specific immune response and demonstrate efficacy in patients with advanced triple-negative breast cancer.
Patient Population: Metastatic triple-negative breast cancer
Target Accrual: 29 patients
Status: Recruiting participants
ClinicalTrials.gov Identifier:
- See more at: https://www.nsabp.org/NSABP-Research/Industry...tNlMV.dpuf
NSABP FB-14
A Phase II Clinical Trial of Pembrolizumab in Combination with the AE37 Peptide Vaccine in Patients with Metastatic-Triple-Negative Breast Cancer
Protocol Chair: Leisha A. Emens, MD, PhD
Protocol Officer: Samuel Jacobs, MD
Primary Objective: To establish the recommended biologic dose of AE37 in combination with pembrolizumab that will enhance the tumor-specific immune response and demonstrate efficacy in patients with advanced triple-negative breast cancer.
Patient Population: Metastatic triple-negative breast cancer
Target Accrual: 29 patients
Status: Recruiting participants
ClinicalTrials.gov Identifier:
- See more at: https://www.nsabp.org/NSABP-Research/Industry...tNlMV.dpuf
(1)
(0)Scroll down for more posts ▼
